 |
Alfred GilmanAmerican scientist, professor of pharmacology
Date of Birth: 01.07.1941
Country:  USA |
Content:
- Early Life and Education
- Research and Discoveries
- Professional Contributions
- Honors and Recognition
- Advocacy
- Legacy
Early Life and Education
Alfred Goodman Gilman was born on July 1, 1941, in New Haven, Connecticut. His father, Alfred Gilman Sr., was a professor at the Yale School of Medicine and co-author of the renowned textbook "The Pharmacological Basis of Therapeutics." Alfred Jr. inherited his father's passion for pharmacology and went on to study at Yale University, graduating in 1962.
He pursued his graduate studies at the University of Western Reserve-Case in Cleveland, Ohio, where he investigated the second messenger cyclic adenosine monophosphate (cAMP). After completing his doctorate in 1971, Gilman joined the University of Virginia in Charlottesville.
Research and Discoveries
In 1981, Gilman became the Chairman of the Department of Pharmacology at the University of Texas Southwestern Medical Center in Dallas. His groundbreaking research focused on G-proteins, cellular components involved in signal transduction. This led to the discovery of G-proteins' role in regulating cellular responses to hormones and other extracellular signals.
In 1994, Gilman shared the Nobel Prize in Physiology or Medicine with Martin Rodbell for their seminal contributions to the understanding of G-proteins. Their discovery revolutionized the field of cell biology and provided insights into the mechanisms underlying numerous diseases.
Professional Contributions
Gilman's contributions extended beyond research. He served as Dean of the University of Texas Southwestern Medical Center from 2005 onwards. Additionally, he was an influential editor of "The Pharmacological Basis of Therapeutics," continuing his father's legacy in shaping the education of medical students.
Honors and Recognition
Throughout his career, Gilman received numerous awards and honors. In 1989, he was awarded the Albert Lasker Award for Basic Medical Research and the Louisa Gross Horwitz Prize. His groundbreaking work culminated in the Nobel Prize in Physiology or Medicine in 1994.
Advocacy
In 2016, Gilman became a prominent advocate for genetically modified organisms (GMOs). He signed a letter urging Greenpeace, the United Nations, and governments worldwide to cease their opposition to GMOs.
Legacy
Alfred G. Gilman's life and work left an enduring mark on the field of pharmacology. His discovery of G-proteins and his advocacy for innovative technologies continue to inspire generations of researchers and shape the future of medical science.
